Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue. (Q41472821)
Jump to navigation
Jump to search
scientific article published on February 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue. |
scientific article published on February 1997 |
Statements
Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue (English)
M Diestelhorst
G K Krieglstein
M Lusky
S Nagasubramanian
1 February 1997